Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Duodenal Mucosa Plays a Key Role in Metabolic Regulation: Emerging Physiology and New Opportunities for Cell-Directed and Barrier-Related Interventions for the Treatment of Diabetes and Obesity.

Diabetes, obesity & metabolism·2026
Same author

Publisher Correction: GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.

Diabetes·2026
Same author

GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

Clinical Potential of GIP in Type 2 Diabetes and Obesity.

Diabetes care·2026
Same author

Acute exogenous acyl-GIP treatment enhances lipid handling and fatty acid oxidation by involving brown fat.

EMBO reports·2025
Same journal

Females Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice.

Diabetes·2026
Same journal

Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus.

Diabetes·2026
Same journal

Targeting the ADA/ADO Axis Rescues β-Cell Failure in Type 2 Diabetes.

Diabetes·2026
Same journal

TXNIP Is Positioned as a Key Mediator of Hyperglycemia-Induced Vascular Senescence.

Diabetes·2026
Same journal

Sex Differences in ER Stress Pathways Are a Key Determinant of β-Cell Proliferation and Resilience.

Diabetes·2026
Same journal

The Mechanism of TNF-α Combined With High Glucose in Regulating Calnexin Aggravates Endoplasmic Reticulum Stress in Endothelial Cell Injury of Diabetic Retinopathy.

Diabetes·2026
See all related articles

Related Experiment Video

Updated: Jul 18, 2025

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.0K

GPCR Promiscuity Reshapes Islet Physiology.

Frans Schuit1, Jonathan E Campbell2

  • 1Gene Expression Unit, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Diabetes
|August 21, 2023
PubMed
Summary
This summary is machine-generated.

Glucagon and glucagon-like peptide 1 (GLP-1) share surprising similarities, acting on the same receptor. This finding reshapes our understanding of how these hormones regulate metabolism, challenging long-held opposing views.

More Related Videos

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.2K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

9.5K

Related Experiment Videos

Last Updated: Jul 18, 2025

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.0K
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.2K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

9.5K

Area of Science:

  • Metabolic regulation
  • Endocrinology
  • Molecular biology

Background:

  • Glucagon and glucagon-like peptide 1 (GLP-1) are derived from the same prohormone.
  • Traditionally, glucagon is viewed as a fasting hormone with catabolic actions, while GLP-1 is seen as a postprandial hormone with anabolic actions.
  • Despite distinct roles, similarities in their actions and receptor binding have been noted.

Purpose of the Study:

  • To re-examine a foundational study on glucagon and GLP-1.
  • To highlight the shared characteristics and receptor interactions of glucagon and GLP-1.
  • To discuss the impact of these findings on current metabolic regulation research.

Main Methods:

  • Literature review and re-analysis of a classic study published in Diabetes.
  • Comparative analysis of the physiological actions of glucagon and GLP-1.
  • Discussion of research advancements stemming from the initial observations.

Main Results:

  • Glucagon and GLP-1 exhibit more commonalities than previously appreciated.
  • Both peptides can act via the same receptor.
  • This shared mechanism challenges the dichotomy of their metabolic roles.

Conclusions:

  • The traditional view of opposing metabolic actions of glucagon and GLP-1 is an oversimplification.
  • Shared receptor activity suggests a more integrated role in metabolic control.
  • Decades of research influenced by this observation have led to a revised understanding of proglucagon hormone function.